Insider Transactions in Q1 2022 at Keros Therapeutics, Inc. (KROS)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 11
2022
|
Jennifer Lachey Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,650
-1.01%
|
$140,450
$53.44 P/Share
|
|
Mar 11
2022
|
Jennifer Lachey Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,650
+2.91%
|
$0
$0.3 P/Share
|
|
Feb 11
2022
|
Jennifer Lachey Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,650
-1.01%
|
$137,800
$52.32 P/Share
|
|
Feb 11
2022
|
Jennifer Lachey Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,650
+2.91%
|
$0
$0.3 P/Share
|
|
Jan 11
2022
|
Jennifer Lachey Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,650
-1.01%
|
$140,450
$53.34 P/Share
|
|
Jan 11
2022
|
Jennifer Lachey Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,650
+2.91%
|
$0
$0.3 P/Share
|
|
Jan 05
2022
|
Jennifer Lachey Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,650
-3.0%
|
$159,000
$60.0 P/Share
|
|
Jan 05
2022
|
Jennifer Lachey Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,650
+2.91%
|
$0
$0.3 P/Share
|
|
Jan 05
2022
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
4,034
-0.23%
|
$233,972
$58.14 P/Share
|
|
Jan 04
2022
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
20,062
-0.68%
|
$1,123,472
$56.97 P/Share
|
|
Jan 03
2022
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
23,555
-0.96%
|
$1,366,190
$58.25 P/Share
|